Univariate Cox analysis of survival data indicated that CD13 expression is a high-risk factor for glioma patients like age, grade, and subtype, while IDH mutation, MGMT methylation, and 1p19q codeletion were low-risk factors (Fig. 1O). This evidence concerns the gene ANPEP and central nervous system cancer.